Severity
Moderate
FDA Devices recall · Reported September 20, 2017
Fujifilm is reporting a corrective action due to an FDA inspection.
Fujifilm Medical Systems U.S.A., Inc. recalled Fujifilm Endoscope Model ED-530XT Product Usage: This product is a medical endosc… - a moderate-severity action.
Fujifilm Endoscope Model ED-530XT Product Usage: This product is a medical endosc… was recalled by Fujifilm Medical Systems U.S.A., Inc. in September 20, 2017. Reason: Fujifilm is reporting a corrective action due to an FDA inspection.. Check the official notice for the remedy. Verify recall #Z-3128-2017 with the FDA Devices before acting.
The recall
Fujifilm Medical Systems U.S.A., Inc. issued this moderate-severity FDA Devices recall-Fujifilm is reporting a corrective action due to an FDA inspection..
Sourced from official FDA Devices enforcement records. Verify recall #Z-3128-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-3128-2017) was formally reported on September 20, 2017, with the manufacturer initiating the action on March 9, 2015. It is classified under Moderate severity (Class II), with a current status of Terminated. Fujifilm Medical Systems U.S.A., Inc. is listed as the recalling firm, operating out of Wayne, NJ. Federal records list the affected scope as 260 manuals in total.
The documented reason for this recall is: Fujifilm is reporting a corrective action due to an FDA inspection. Distribution data in the federal record shows the product reached: US Nationwide Distribution. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,422 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
260 manuals in total
Related Recalls
6
0 from same agency
Fujifilm Endoscope Model ED-530XT Product Usage: This product is a medical endoscope for the duodenum and upper GI tract. It is intended for observation, diagnosis, and endoscopic treatment of the esophagus, stomach and duodenum. This product is not used for any other purposes.
Fujifilm is reporting a corrective action due to an FDA inspection.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-3128-2017 |
| Date reported | September 20, 2017 |
| Date initiated | March 9, 2015 |
| Recalling firm | Fujifilm Medical Systems U.S.A., Inc. |
| Firm location | Wayne, NJ |
| Affected scope | 260 manuals in total |
| Distribution | US Nationwide Distribution |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-07-02
· 2026-07-02
· 2026-06-25
· 2026-06-25
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported September 20, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.